Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,083 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,083 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,083 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,083 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,083 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,083 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,083 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
23 Mar 2026
Wolf Kinsey See Remarks
Sold at will
$58.91K 400 at 147.28
42.4%
Not planned
23 Mar 2026
Foster Karen A. Chief Quality and Operations
Sold on a plan
$49.40K 2,577 at 19.17
2.3%
Planned (10b5-1)
23 Mar 2026
Brass Lorin L. Director
Sold at will
$45.00K 1,000 at 45.00
5.4%
Not planned
23 Mar 2026
Yi Steven See Remarks
Sold on a plan
$38.68K 4,000 at 9.67
0.1%
Planned (10b5-1)
23 Mar 2026
Sold on a plan
$36.70K 30,047 at 1.22
12.7%
Planned (10b5-1)
23 Mar 2026
Sold at will
$34.16K 4,000 at 8.54
0.7%
Not planned
23 Mar 2026
Zalatoris Timmi Chief Human Resources Officer
Sold at will
$33.45K 426 at 78.52
3.2%
Not planned
23 Mar 2026
Grady Jason Director
Sold at will
$32.51K 50,000 at 0.65
16.7%
Not planned
23 Mar 2026
TAYLOR DIAN C Director
Sold at will
$31.25K 1,000 at 31.25
1.0%
Not planned
23 Mar 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$29.89K 10,000 at 2.99
5.1%
Planned (10b5-1)
23 Mar 2026
HALE BRETT CFO and CAO
Sold at will
$29.27K 24,188 at 1.21
8.1%
Not planned
23 Mar 2026
TEISSEYRE THOMAS Chief Operating Officer
Sold at will
$29.27K 24,188 at 1.21
6.4%
Not planned
23 Mar 2026
Faust Eric D Chief Risk Officer
Sold at will
$28.88K 1,148 at 25.16
17.2%
Not planned
23 Mar 2026
Longhito Christopher FMR SVP & CSCO
Sold at will
$25.63K 819 at 31.30
10.9%
Not planned
23 Mar 2026
SHELTON JERRELL President, CEO
Sold at will
$23.67K 2,894 at 8.18
0.3%
Not planned
23 Mar 2026
Romaine Mark Chief Operating Officer
Sold at will
$20.58K 435 at 47.31
0.3%
Not planned
23 Mar 2026
Lovisotto Fernando Head of Global IP&S · indirect
Sold on a plan
$20.46K 1,994 at 10.26
0.2%
Planned (10b5-1)
23 Mar 2026
Sabino Anthony John Chief Executive Officer
Sold on a plan
$20.08K 8,033 at 2.50
4.1%
Planned (10b5-1)
23 Mar 2026
Moreadith Randall Chief Scientific Officer
Sold on a plan
$18.57K 6,500 at 2.86
100%
Sold half or more
23 Mar 2026
Batill Eric General Counsel
Sold at will
$14.28K 2,695 at 5.30
3.3%
Not planned
23 Mar 2026
Sold at will
$13.58K 2,562 at 5.30
2.0%
Not planned
23 Mar 2026
Sold at will
$12.25K 2,311 at 5.30
1.8%
Not planned
23 Mar 2026
Sawicki Mark W Chief Scientific Officer
Sold at will
$10.97K 1,341 at 8.18
1.3%
Not planned
23 Mar 2026
International Finance Corp 10% owner · indirect
Sold at will
$10.89K 2,162 at 5.03
0.0%
Not planned
23 Mar 2026
Hawkins Jeffrey Alan President & CEO
Sold at will
$10.04K 12,149 at 0.83
0.3%
Not planned
23 Mar 2026
Vieceli John S. Chief Product Officer
Sold at will
$9.29K 11,239 at 0.83
1.0%
Not planned
23 Mar 2026
SROKA DIANA Director
Sold on a plan
$9.09K 1,343 at 6.77
0.9%
Planned (10b5-1)
23 Mar 2026
Mussetter Sarah A. CHIEF LEGAL OFFICER
Sold at will
$9.09K 2,913 at 3.12
2.7%
Not planned
23 Mar 2026
STEFANOVICH ROBERT Chief Financial Officer
Sold at will
$8.95K 1,094 at 8.18
0.4%
Not planned
23 Mar 2026
Ribeiro Sergio Passos Chief Financial Officer · indirect
Sold on a plan
$7.39K 720 at 10.26
0.2%
Planned (10b5-1)
23 Mar 2026
Sold at will
$5.92K 1,117 at 5.30
0.9%
Not planned
23 Mar 2026
LaPointe Christian GC & Corp. Secretary
Sold at will
$5.05K 6,110 at 0.83
0.5%
Not planned
23 Mar 2026
Sadri Ali Chief Technology Officer
Sold on a plan
$5.00K 1,000 at 5.00
0.8%
Planned (10b5-1)
23 Mar 2026
SUEN JACOB President and CEO
Sold on a plan
$5.00K 1,000 at 5.00
0.4%
Planned (10b5-1)
23 Mar 2026
Keyes Jeffry R. Chief Financial Officer
Sold at will
$3.66K 4,422 at 0.83
0.2%
Not planned
23 Mar 2026
Griffith Jesse Chief Operations Officer
Sold at will
$2.62K 839 at 3.12
2.0%
Not planned
23 Mar 2026
Leverone Jason A. Chief Financial Officer
Sold at will
$1.25K 301 at 4.16
1.8%
Not planned
23 Mar 2026
Miller Timothy William Vice President, Sales
Sold on a plan
$437.00 437 at 1.00
1.0%
Planned (10b5-1)
23 Mar 2026
Saccomano Nicholas A President and CEO
Sold at will
$357.46 86 at 4.16
1.2%
Not planned
20 Mar 2026
BINDLEY WILLIAM E Director · indirect
Sold at will
$105.99M 3,570,677 at 29.68
44.4%
Not planned
20 Mar 2026
Sold at will
$105.99M 3,570,677 at 29.68
44.4%
Not planned
20 Mar 2026
Salentine Thomas J Jr Director · indirect
Sold at will
$105.99M 3,570,677 at 29.68
44.4%
Not planned
20 Mar 2026
SLTA IV (GP), L.L.C. Director · indirect
Sold at will 35×
$74.40M 450,001 at 165.34
100%
Sold half or more
20 Mar 2026
SLTA V (GP), L.L.C. Director · indirect
Sold at will 35×
$74.40M 450,001 at 165.34
100%
Sold half or more
20 Mar 2026
Lance Ryan Michael Chairman and CEO
Sold at will
$64.49M 506,800 at 127.26
98.7%
Sold half or more
20 Mar 2026
STEVENS MARK A Director · indirect
Sold at will 2×
$38.50M 221,682 at 173.68
2.9%
Not planned
20 Mar 2026
Ackerman John Director · indirect
Sold at will 2×
$32.75M 1,103,364 at 29.68
76.2%
Sold half or more
20 Mar 2026
Pharmacy Investors, LLC Member of 10% owner group
Sold at will
$24.57M 827,636 at 29.68
44.4%
Not planned
20 Mar 2026
Burke Fred See Remarks
Sold at will
$19.93M 671,432 at 29.68
44.4%
Not planned
20 Mar 2026
Sold at will 2×
$16.60M 340,000 at 48.84
1.5%
Not planned
Showing 26,251–26,300 of 46,083. ← Newer Page 526 of 922 Older →